Avantor, Inc. $AVTR Shares Sold by HighTower Advisors LLC

HighTower Advisors LLC decreased its holdings in Avantor, Inc. (NYSE:AVTR) by 42.6% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 87,620 shares of the company’s stock after selling 65,116 shares during the quarter. HighTower Advisors LLC’s holdings in Avantor were worth $1,004,000 as of its most recent filing with the SEC.

Several other institutional investors have also modified their holdings of the business. Royal Bank of Canada raised its stake in Avantor by 104.3% during the first quarter. Royal Bank of Canada now owns 203,738 shares of the company’s stock valued at $3,302,000 after buying an additional 104,022 shares in the last quarter. Empowered Funds LLC raised its stake in Avantor by 40.3% during the first quarter. Empowered Funds LLC now owns 17,659 shares of the company’s stock valued at $286,000 after buying an additional 5,075 shares in the last quarter. Cetera Investment Advisers raised its stake in Avantor by 40.2% during the second quarter. Cetera Investment Advisers now owns 40,289 shares of the company’s stock valued at $542,000 after buying an additional 11,543 shares in the last quarter. Quantbot Technologies LP acquired a new stake in Avantor during the second quarter valued at approximately $232,000. Finally, Arrowstreet Capital Limited Partnership raised its stake in Avantor by 214.9% during the second quarter. Arrowstreet Capital Limited Partnership now owns 124,076 shares of the company’s stock valued at $1,670,000 after buying an additional 84,679 shares in the last quarter. Institutional investors and hedge funds own 95.08% of the company’s stock.

Wall Street Analysts Forecast Growth

Several analysts have issued reports on AVTR shares. Wall Street Zen cut Avantor from a “buy” rating to a “hold” rating in a research note on Saturday, May 30th. Barclays cut their price objective on Avantor from $8.50 to $7.00 and set an “underweight” rating on the stock in a research note on Tuesday, April 14th. Jefferies Financial Group restated an “underperform” rating and set a $8.00 price objective on shares of Avantor in a research note on Thursday, February 12th. Wolfe Research cut Avantor to an “underperform” rating and set a $7.00 price objective on the stock. in a research note on Monday. Finally, Zacks Research upgraded Avantor from a “strong sell” rating to a “hold” rating in a research note on Thursday, April 30th. Two analysts have rated the stock with a Buy rating, eleven have assigned a Hold rating and three have assigned a Sell rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Reduce” and an average price target of $10.57.

Insider Activity

In related news, Director Gregory T. Lucier bought 10,000 shares of the stock in a transaction dated Friday, May 8th. The stock was bought at an average cost of $8.32 per share, with a total value of $83,200.00. Following the completion of the acquisition, the director owned 60,000 shares of the company’s stock, valued at $499,200. This trade represents a 20.00% increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Sanjeev K. Mehra bought 125,000 shares of the stock in a transaction dated Tuesday, March 10th. The shares were bought at an average cost of $8.01 per share, with a total value of $1,001,250.00. Following the completion of the acquisition, the director directly owned 475,000 shares of the company’s stock, valued at approximately $3,804,750. The trade was a 35.71% increase in their position. The disclosure for this purchase is available in the SEC filing. Over the last ninety days, insiders purchased 160,000 shares of company stock valued at $1,287,950. 0.28% of the stock is currently owned by insiders.

Avantor Stock Up 5.0%

NYSE:AVTR opened at $9.52 on Friday. The firm has a market capitalization of $6.50 billion, a PE ratio of -11.75, a price-to-earnings-growth ratio of 5.26 and a beta of 0.97. The stock has a 50 day moving average of $8.15 and a 200-day moving average of $9.68. Avantor, Inc. has a 52 week low of $7.26 and a 52 week high of $15.93. The company has a current ratio of 1.76, a quick ratio of 1.17 and a debt-to-equity ratio of 0.68.

Avantor (NYSE:AVTR) last posted its earnings results on Wednesday, April 29th. The company reported $0.17 EPS for the quarter, beating the consensus estimate of $0.16 by $0.01. The company had revenue of $1.58 billion during the quarter, compared to analyst estimates of $1.54 billion. Avantor had a positive return on equity of 9.95% and a negative net margin of 8.42%.The business’s revenue was up .0% compared to the same quarter last year. During the same period in the prior year, the company earned $0.23 earnings per share. Analysts predict that Avantor, Inc. will post 0.79 EPS for the current year.

Avantor Company Profile

Avantor, Inc (NYSE:AVTR) is a global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company delivers essential solutions that support research, development, production and safety applications. Its product portfolio spans from high-purity chemicals and reagents to biologics and cell culture media, as well as lab equipment, consumables and custom manufacturing services.

Avantor’s offerings are organized across two primary segments.